Download - FIFTH COMMUNITY PHARMACY AGREEMENT ... COMMUNITY PHARMACY AGREEMENT CONSULTATION Current as at 30 June 2014 FIFTH COMMUNITY PHARMACY AGREEMENT: OVERVIEW OF STAKEHOLDER CONSULTATION

FIFTH COMMUNITY PHARMACY AGREEMENT CONSULTATION

Current as at 30 June 2014

FIFTH COMMUNITY PHARMACY AGREEMENT: OVERVIEW OF STAKEHOLDER CONSULTATION ACTIVITIES TO 30 JUNE 2014

5CPA component Consultation activity With whom Timeframe Action taken in response 5CPA programmes • Consumer views on the services

and advice provided by pharmacies to consumers;

• The location of pharmacies; • Issues relevant to competition

between pharmacies; and • Increased accountability of

pharmacy owners for the professional pharmacy services provided to consumers.

• CHF December 2009 – December 2010

• Advice provided informed policy options and negotiations for 5CPA.

Medication Use Reviews (MedsCheck) and Diabetes Medication Management Service (Diabetes MedsCheck)

Advice sought on patient eligibility for the MedsCheck and Diabetes MedsCheck pilots

• PRG

December 2010 – June 2012

• Inclusion of ‘improved adherence’ to the aims of the programme.

• Use of broad patient eligibility criteria initially for the pilot that could be refined to inform the national roll-out.

• Added ‘significant medical event and complexity/type of administration’ as an additional indicator to number of drugs included.

• The interim evaluation report was provided to the PRG on 1 February 2012 for comment. Further consultation may be undertaken following finalisation of the evaluation in April 2012.

Two stage testing functionality of the Assessment Tool

• PSA • AACP • Guild • Practising Community

Pharmacists

June 2011 and July 2011

• Feedback incorporated into Assessment Tool.

Consultation on community pharmacy software requirements

• MSIA Finalised mid 2012 • Developing vendor resource documents to inform possible open source software solutions linking dispense and claiming functions of the planned system.

Current as at 30 June 2014 2

5CPA component Consultation activity With whom Timeframe Action taken in response Home Medicines Review (HMR)

Development of new direct referral pathway to HMR

• PSA • Guild • AACP • Other stakeholder

consultations under 4CPA HMR research project

December 2008 – October 2011

• Implementation of a new direct referral pathway to HMR from 1 October 2011.

• Update of existing professional practice guidelines to incorporate the new referral pathway by PSA.

Home Medicines Review (HMR)

Development a hospital referral pathway for HMRs. HMR hospital referral pathway stakeholder consultation workshop 29 June 2012

• PRG • Guild • AACP • State and Territory

health departments • RACP • APHA • ACSQHC • SHPA • AGPN • Public consultation

December 2008 – Ongoing

• A consultation paper was released on 9 December 2011 and submissions closed on 20 January 2012. This paper was developed with input from PRG, and 75 submissions were received.

• Summary of the consultation responses provided to PRG for information on 19 April 2012.

• Further stakeholder consultations will be undertaken prior to finalisation of a HMR Hospital Referral Pathway.

• . Two hospitals selected (in Hobart and Melbourne) with the Department ready to commence, pending agreement on a commencement date with the Guild. A staggered national implementation is planned, which will be informed by data from the two initial sites.

HMR (and other MMR programmes) changes

• PRG April 2013- ongoing • Provide advice to inform options to restructure the HMR (and other MMR Programmes fee structure) to support programme sustainability and integrity.

HMR research project to collate and assess evidence in order to recommend better targeting of HMR patient eligibility criteria

• SHPA • PSA • Guild • PRG

March 2013 – ongoing

• Joint involvement in development of RFT • Ongoing input into project outcomes.

Residential Medication Management Review (RMMR)

Development of requirement for RMMR services to be collaborative (referred by a general practitioner)

• PSA • Guild • Other stakeholder

consultations under 4CPA RMMR research project

May 2010 – October 2011

• The change to require all reviews to be collaborative was implemented on 1 October 2011.


5CPA component Consultation activity With whom Timeframe Action taken in response Development of policy changes to separate RMMR services from Quality Use of Medicines services. PRG members asked to seek views from their members/organisations regarding unforeseen impacts from 1 October 2011 changes to RMMR programme

• PSA • Guild • Other stakeholder

consultations under 4CPA RMMR research project

• PRG

May 2010 – October 2011 August 2012

• Splitting payments for RMMR and QUM services from 1 October 2011.

• Update of the existing professional practice guidelines to incorporate changes to the RMMR programme.

• Provide feedback as it arises.

Rural Pharmacy Workforce

Eligibility changes to a number of elements of RPWP resulting from PhARIA update and restrictions to PhARIA 2-6

• ARHEN • PSA • Guild • Pharmacy academics

from various universities

2011 – Ongoing • Consultation with AHREN, PSA and PRG undertaken.

• Changes resulting from update to PhARIA classification implemented in July 2012.

• Exceptional circumstance criteria under development by Guild for 1) Rural and Remote Continuing Education

Allowance 2) Rural Intern Training Allowance 3) Intern Incentive Allowance for Rural

Pharmacies. 4) Rural Student Placement Allowance.

Advice on programme implementation, transitional arrangements and exceptions for the Rural Pharmacy Continuing Professional Education Allowance and the Rural Pharmacy Student Placement Allowance

• PRG December 2011 – January 2012

• Consultation undertaken over mid 2011 - January 2012.

• Advice provided to PRG on 19 April 2012 regarding changes to RPWP.

Rural Pharmacy Maintenance Allowance

Development of an updated model, in the context of a changing rural index

• Guild • DHS • University of Adelaide

Late 2010 – July 2012

• Implementation complete and pharmacy owners advised where RPMA eligibility has not continued.

• An exceptional circumstance process is being managed by the Guild.


5CPA component Consultation activity With whom Timeframe Action taken in response Section 100 Support Allowances to Remote Area Aboriginal Health Services (AHS)

Consultation on potential changes to programme arrangements

• PRG • Guild • Other stakeholder

consultations under 4CPA evaluation of Indigenous pharmacy programmes

• Over 250 attendees at the Indigenous Joint Forum

2010-11 – Ongoing

• Indigenous Joint Forum held in Melbourne on 26/27 March 2012 provided opportunities for further consultation with all delegates (over 250 delegates attended).

• Joint Forum outcomes have been collated, consolidated and considered by QUMAX Reference Group and the 5CPA PRG. No final decisions regarding programme changes have been made.

Consultation on the recommendations from the Senate inquiry into the supply arrangements of PBS medicines to remote area AHSs (which included consideration of support arrangements)

• PRG

November 2011 - ongoing

• Government is in the process of finalising its response to the Senate inquiry recommendations.

QUM Framework to support rural and urban Aboriginal Health Services

Consultation on potential changes to programme arrangements

• PRG • Guild • Other stakeholder

consultations under 4CPA evaluation of QUMAX programme Over 250 attendees at the Indigenous Joint Forum

2010-11 – Ongoing

• Updated programme arrangements have been implemented.

• Indigenous Joint Forum held in Melbourne on 26/27 March 2012 provided opportunities for further consultation with all delegates (over 250 delegates attended).

• Joint Forum outcomes have been collated, consolidated and considered by QUMAX Reference Group and the 5CPA PRG.

Taking into account the findings from the 4CPA evaluation of QUMAX, consultation on changes to the QUMAX programme

QUMAX Programme Reference Group, made up of: • DoHA • Guild • NACCHO • PSA

Ongoing • The new QUMAX programme model has been developed in the context of input from all stakeholders and implemented.

• QRG met on 14 February 2012 and 8 March 2012 to discuss QUMSP and NACCHO State Affiliate support arrangements post 30 June 2012.

• QRG met on 22 June 2012 – QUMSP and NACCHO State Affiliate support arrangements extended to 31 December 2012.

• From 1 Jan 2013, online education and training resources are being implemented to assist participating Aboriginal Health Services with their application, workplan and reporting requirements. Further assistance will also be available through Guild and NACCHO telephone hotlines.


5CPA component Consultation activity With whom Timeframe Action taken in response Pharmacy Practice Incentive (PPI) and Accreditation • PPI: Clinical

Interventions by Pharmacists

Consultation regarding priorities for programme funding under 5CPA

Broad stakeholder input through PPSAC 4CPA Research & Development Steering Committee and 4CPA Research & Development project (PROMISe).

October 2008 – May 2010

• Inclusion of Clinical Interventions as a priority programme area in 5CPA.

Activities to support the roll-out of the PPI Programme under 5CPA

PSA, with Expert Reference Group involvement, including Guild, SHPA, APESMA, ACP, APC, AACP, PDL, CHF, RACGP, AGPN, AMA, NPS, Carers Aust, ASMI

September 2010 - 2011

• Development of Professional Standards and Guidelines and online educational resources by PSA.

• PPI: Support for the Provision of Dose Administration Aids

Consultation about the evaluation of the 4CPA DAA/PMP Programme

• Broad stakeholder input under 4CPA DAA/PMP evaluation.

September 2007 – June 2009

• Inclusion of a DAA component in the 5CPA.

• PPI: Staged supply support allowance

Consultation about the 4CPA review of Staged Supply regarding implications for community pharmacies in the administration of Staged Supply of PBS medicines.

• AMA • CHF • State and territory

health departments • SHPA • ANCD • diverse range of other

stakeholders

February 2010 – 2011

• Inclusion of Staged Supply component in 5CPA.

Consultation on activities to support the roll-out of the PPI Programme under 5CPA

• PSA with Expert Reference Group involvement.

September 2010 – 2011

• Development of professional Standards and Guidelines and online educational resources by PSA.


5CPA component Consultation activity With whom Timeframe Action taken in response • PPI: Funding to

support the Accreditation System and roll-out of Additional Programmes to Support Patient Services

Development of a Community Pharmacy Service Charter

• ACSA • AHPA • APESMA • AACP • AGPN • AHPRA • AHRC • AMA • ANF • ASMI • Carers Australia • CHF • Council of the Ageing • NACCHO • NAPSA • NEDA • NPS • NRHA • PSA • PBA • SHPA • ACSQHC • Guild

December 2010 – June 2011

• Convened a workshop in December 2010 to discuss how to tailor the Australian Charter of Healthcare Rights to be suitable for a community pharmacy setting.

• Draft concepts for the Community Pharmacy Charter were developed and distributed for wider consultation and comment.

• The Community Pharmacy Service Charter was finalised and implemented in June 2011.


5CPA component Consultation activity With whom Timeframe Action taken in response Research and Development

Workshop to inform 5CPA research priorities and identify a list of potential projects for research focus under the 5CPA

Approximately 175 participants attended a workshop representing a wide range of stakeholders that included: professional and industry organisations, government, peak bodies and consumers. The Advisory Panels comprise representatives from the following organisations: • PSA • CHF • ASMI • SHPA • AACP • AMA • RACGP • Illuminate Health

Consulting • NRHA • Health Consumers of

Rural & Remote Australia

• PBA • The George Institute

for Global Health • NMHCCF

March 2010 and April 2011

A number of research priority areas were recommended, including six that were subsequently funded under the 5CPA programme: • Mental Health • Professional Integration (Collaboration) • Rural • Health Literacy • Consumer Needs • Chronic Illness The Rural project has subsequently been discontinued. Establishment of Advisory Panels to oversee the research projects. Advisory panels select tenders and provide advice and guidance on the individual research projects.

Inclusion of a further Research and Development project on HMR Patient Eligibility

• Guild March 2013 - October 2013

• Commencement in October 2013 of HMR Patient Eligibility project.

Supply and PBS claiming from a medication chart in Residential Aged Care Facilities

Review of the Existing Supply Arrangements of PBS Medicines in Residential Aged Care Facilities and Private Hospitals under 4CPA

• Aged care sector • Private hospitals • Medical practitioners • Nurses • Pharmacists

Residents and patients

September 2009 • Inclusion of ‘Medication Charts’ initiative in 5CPA.

• Informing policy parameters of initiative.

Initiative Development Meetings

• Guild • DHS • OACQC • ACSQHC

August 2010 – October 2012

• Development of a public consultation paper. • Identification and resolution of policy issues in

relation to programme design and implementation.

• Agreement on elements of the programme that required broader consultation.


5CPA component Consultation activity With whom Timeframe Action taken in response Supply and PBS claiming from a medication chart in Residential Aged Care Facilities

Draft content of consultation paper for comment

• PRG • AMA

November – December 2010

Changes were made to the draft public consultation papers as a result of PRG advice including: • increased emphasis on the reduced

administrative burden for the pharmacist; • ensured consistent use of the term “prescriber”,

as opposed to medical practitioner or doctor; • included further information on the link with

QUM policy and the Authority medicines process.

Call for responses on parameters of the initiative through the release of a consultation paper

• PRG • Targeted aged care

stakeholders • Broad range of

pharmacy and prescribing industry stakeholders

• State and territory health authorities

• The general public

March 2011 – April 2011

• Responses informed legislative amendments currently before parliament.

• Highlighted the importance of safety and quality use of medicines requirements which have resulted in the Department engaging the ACSQHC to develop the National Residential Medication chart.

• Informed issues to be address in relation to implementation and change management activities.

Site visits to inform policy and implementation issues

• Aged care facilities • Public and private

hospitals • Community

pharmacies • Medication packaging

companies

November 2010 – June 2011

• Inform legislative amendments to the National Health Act 1953, identify policy issues and potential change management issues.

Discussions with the AMA to identify issues for prescribers

• AMA November 2010, June 2011, January 2012 and April 2012

• Resolved the issue about how ‘repeat’ medication orders will be dealt with on the chart

• Informed communication requirements for prescribers.

Meetings with representatives from state and territory departments of health

All jurisdictions February, August, November, December 2011 and March 2012.

• Identified and incorporated key issues into the development and implementation of the initiative, including informing legislative amendments.

• Provided information in relation to Commonwealth legislative and regulatory changes.


• MSIA • ACIVA

May 2011 to December 2012

• Identified requirements for software vendors to support the transition to new arrangements.


5CPA component Consultation activity With whom Timeframe Action taken in response Supply and PBS claiming from a medication chart in Residential Aged Care Facilities

National Residential Medication Chart Reference Group – established by the ACSQHC

• Aged Care Facility representation

• DoHA • Medicare • Consumer • Guild • AMA • ACAA • RACGP • PSA • DVA

October 2011 – ongoing

• Providing advice and guidance to the ACSQHC on the development and implementation of the National Residential Medication Chart project.

Department of Veterans Affairs • DVA November 2011 • Identified issues that impacted on ensuring RPBS access is maintained and inform of legislative amendments to the National Health Act 1953.

Consultation regarding exemptions required from NSW Ministry of Health

• NSW Ministry of Health

• ACSQHC

July 2012 - ongoing • Provided advice to NSW Ministry of Health on specific elements of the chart to support the granting of the exemptions to allow the phased implementation to commence.

Management of programme implementation

• ACSQHC, state governments, residential aged care peak bodies, DSS.

October 2011 – ongoing

• Managed the implementation of the National Residential Medication Chart project.

Continued Dispensing of PBS Medicines in defined circumstances

Initiative Development Meetings

• Guild • DHS • PSA


• Policy issues in relation to programme design, Medicare system and implementation identified and resolved.

• Agreement on elements of the programme that required broader consultation

• Development of practice guidelines.


5CPA component Consultation activity With whom Timeframe Action taken in response Draft content of consultation paper for comment

• PRG • AMA

November - December 2010

Changes to the consult papers were made to papers as a result of PRG advice including: • changing name of the initiative from Medication

Continuance to Continued Dispensing of PBS Medicines in defined circumstances.

• communication from pharmacists to prescribers when a continued dispensing even has occurred built in as a mandatory step.

• indemnity issues being explored including if the indemnity lies with the original prescriber or the pharmacist.

• the development of pharmacist education and professional protocols.

Continued Dispensing of PBS Medicines in defined circumstances

Call for responses on parameters of the initiative through the release of a consultation paper

• PRG • targeted aged care,

pharmacy and prescribing industry stakeholders


• The general public

March – April 2011

• Responses informed legislative amendments currently before parliament.

• The Department engaged the PSA to develop professional protocols and guidelines for pharmacists undertaking a continued dispensing supply.

• Prior clinical review is mandatory prior to a continued dispensing supply.

• Informed issues to be addressed in relation to implementation and change management activities.

• Released FACT SHEET at APP conference in March 2012.

Meetings with representatives from state and territory departments of health

• All jurisdictions February, August, November, December 2011 and March 2012.

• Identified and incorporated key issues into the development and implementation of the initiative, including informing legislative amendments.

• Provided information in relation to Commonwealth legislative and regulatory changes.

Sought advice from PDL with regard to pharmacy indemnity issues

• PDL August 2011 • Advice provided will support ongoing implementation.


• MSIA May 2011 – December 2012

• Identify requirements for software vendors to support the transition to new arrangements.

PSA – Expert Advisory Group – industry consultation seeking comment on professional guidelines

• AMA • AACP • NPS • APC • PDL • CHF • Tasmanian

Department of Health

October – November 2011

• Feedback received from stakeholders has been incorporated into the development of the professional guidelines.


5CPA component Consultation activity With whom Timeframe Action taken in response Electronic recording and reporting of controlled drugs

Initiative development meetings • Guild • Medicare


• Determined the direction of the initiative and drafted the public consultation paper.

Draft consultation paper sent to PRG for comment

• PRG • AMA

November - December 2010

• Acknowledged that the PRG was broadly supportive of the initiative and the proposed parameters.

Meeting with the Office of the Australian Information Commissioner

• Office of the Australian Information Commissioner

January 2011 • A Privacy Impact Assessment of the initiative was conducted.

Electronic recording and reporting of controlled drugs

Call for responses on parameters of the initiative through the release of a public consultation paper

• PRG • Targeted health

sector stakeholders including health professionals and software vendors


• General public

March 2011 – April 2011

• Acknowledged that the initiative was broadly supportive and key advice was considered and incorporated into the development of the next stages of the initiative, including within the High Level requirements for the system released as a part of the Department’s Request for Expression of Interest 371/1011.

• Released FACT SHEET on 5CPA website on 26 April 2012.

Meetings with state and territory health departments

• Representatives of the departments of health in all eight jurisdictions

February 2011 – August 2012

• Input from the jurisdictions was used to inform the system development and policy parameters and implementation options for the initiative.

State and Territory ERRCD Steering Group

• Representatives of the department of health in all eight jurisdictions

August 2012 - ongoing

• Input is being used to ensure that the objectives of the initiative are achieved, risks are identified and the initiative is implemented and operated consistent with applicable legal and policy obligations.

Discussions with the AMA to identify issues for prescribers

• AMA February and April 2012

• Considered options for the ‘interface’ with practice management software.

Meetings with the Pharmacy Guild • Guild February 2012 - ongoing

• Considered implementation options for the development of the electronic Controlled Drugs Register.

Consultation on community pharmacy and prescriber software requirements

• MSIA February 2012 - ongoing

• Identify requirements for software vendors to support the transition to new arrangements.

Discussions with NeHTA regarding messaging and content standards

• NeHTA September 2012 – ongoing

• Continue to liaise with NeHTA to ensure the ERRCD system aligns with eHealth standards.


5CPA component Consultation activity With whom Timeframe Action taken in response Pharmacy Location Rules

• Independent review conducted by Urbis Pty Ltd, including: Stakeholder interviews Online survey

to review the effectiveness and efficiency of the Rules

• Guild • DHS • RACGP • AMA • PSA • ACPA • APESMA • SPHA • PBA • CHF • NRHA • Primary Health Care • Four individual

brokers who regularly act on behalf of applicants

• Online survey received from 15 of the 23 previous applicants.

January 2010 - June 2010

• Responses informed the development of the determination introduced into parliament.

• Decision that further consultations were needed with ACPA and DHS.

• Stakeholder workshop hosted by Department and the Guild

• Meetings with the Guild • Meet with the Consumers Health

Forum staff to broadly outline the proposed amendments to the Rules.

• DHS • ACPA

October 2010 – October 2011

• Development of the new location rules. • Following the registration of the determination,

stakeholders were advised of the changes via letters to community pharmacies, agents who act on behalf of applicants and other stakeholders.

• Frequently Asked Questions and a revised handbook to assist potential applicants are available on the Department’s website. Articles were distributed to pharmacy journals for potential inclusion in online and printed publications.

Ongoing consultation with DHS regarding administrative processes relevant to the Pharmacy Location Rules

• DHS Mid 2011 – ongoing

Meetings with the Guild to discuss proposed minor amendments to the Pharmacy Location Rules to address anomalies within the Rules.

• Guild Late 2012 – mid 2013

• Proposed minor amendments to address anomalies in the Rules have been agreed.

• Drafting of a new determination has commenced.

Pharmacy Location Rules

Pharmacy Location Rules Issues and Opportunities Workshop; and Pharmacy Location Rules Process Discovery and Improvement Workshop

• Health (PAB and LSB) • DHS • ACPA Chair

April / May 2013 • Considering areas where application and administrative processes could be streamlined and possible improvements to the section 90 application process.


5CPA component Consultation activity With whom Timeframe Action taken in response Electronic Prescriptions

Payment processes for EPF claiming system by DHS.

• Guild • MSIA • DHS • PES vendors

June 2012 – ongoing

• DHS extends the EPF payment process to implement an EPF payment process direct to PES vendors and to maintain the 15 cents EPF payment to pharmacy.

Consultations to manage Prescription Exchange Service interoperability and pharmacy participation in ETP

• eRx and Medisecure • Guild (later) • DHS (later)

April 2012 – ongoing

• PES Interim Interoperability Initiative.

Consultation about the parameters and definitions to apply to the Guild proposal to pay pharmacy 15cents for each electronic prescription dispensed

• Guild • DHS

Early 2010 – ongoing

• 15 cents Electronic Prescription Fee (EPF) included in the Fifth Agreement signed on 3 May 2010.

• Agreement to pay PES vendors 85 cents EPF from 1 July 2012 to 31 Dec 2012 and 35 cents EPS from 1 Jan 2013 to 30 June 2013.

CSO Funding Pool CSO consultation workshops

• Pharmaceutical wholesalers

• CSO Administration Agency

• TGA Guild

June 2010 – October 2010

• Changes to the CSO Service Standards and changes to the Deeds of Agreement with CSO Distributors.

• The revised Code of Good Wholesaling Practice is being used within the CSO framework002E.

Collection of under co-payment data

Development and implementation of the under co-payment data collection measure, including: • development of changes to

Medicare processes, • development of changes to

pharmacy dispensing software; • development of a communications

strategy for pharmacy; • letters providing information to

hospitals and other stakeholders; • updating of information on the

DHS and DoHA websites; and • consideration of post-

implementation issues.

• MSIA • Pharmacy software

vendors • Guild • DHS • DVA • Peak stakeholder

bodies (CHF, PSA, SHPA, AFSPA, APHA, RACP, RACGP, AMA)

January 2010 – May 2012

• Technical issues discussed and progressed; • Vendor resource document finalised; • Monitoring of collection of data submissions

from 1 April 2012. • Amended legislative instruments regarding the

collection of under co-payment data.

Fifth Community Pharmacy Agreement Evaluation Framework

Ongoing stakeholder engagement to update the Evaluation Framework annually or as required during the Fifth Agreement.

• The Evaluation Framework is available on the Department’s website and the Department invites public comment from interested stakeholders

Ongoing • The Evaluation Framework and Department website have been updated are based on comments received to date.


5CPA component Consultation activity With whom Timeframe Action taken in response Combined Review of the Medication

Management Review Programmes under the Fifth Agreement.

• PRG • Consumers • Community

Pharmacist • Accredited

Pharmacists • Hospital Pharmacists • General Practitioners • RACF residential and

nursing staff • Other Health

Professionals

July 2013 - Dec 2014

• Advice, opinions, information and data sought from participating stakeholders to enable response to evaluations

• Stakeholder consultation undertaken through focus groups, interviews and surveys

Combined Thematic Review of Access, Consumer Experience and Quality Use of Medicines under the Fifth Agreement.

• PRG • Pharmacy Guild of

Australia; • Pharmacy owners; • Pharmacist workforce

(including Community pharmacists);

• Accredited pharmacists and relevant hospital practitioners;

• Pharmaceutical Society of Australia;

• Australian Association of Consultant Pharmacists;

• Society of Hospital Pharmacists of Australia; and

• Professional Pharmacists Australia (formerly known as APESMA).

• Consumers; • Consumers Health

Forum of Australia; • Council on the

Ageing; • Carers Australia; • National Aboriginal

Community Controlled Health Organisation;

• Mental Health Council of Australia;

Aug 2014 – March 2015


• Stakeholder consultation undertaken through focus groups, interviews, workshops and research analysis


5CPA component Consultation activity With whom Timeframe Action taken in response • National Rural Health

Alliance; • National Aged Care

Health Alliance; • National Prescribing

Service; • Medicines Australia; • Australian Medical

Association; • Medicare Locals

Network; and • Royal Australian

College of General Practitioners.

Review of Governance Structures established under the Fifth Agreement.

• ACC • PRG • Pharmacy Guild of

Australia • Pharmaceutical

Society of Australia; • Australian Association

of Consultant Pharmacists;

• Society of Hospital Pharmacists of Australia; and

• Professional Pharmacists Australia (formerly known as APESMA).

• Consumers; • Consumers Health

Forum of Australia; • Council on the

Ageing; • Carers Australia; • National Aboriginal

Community Controlled Health Organisation;

• Mental Health Council of Australia;

• National Rural Health Alliance;

• National Aged Care Health Alliance;

• National Prescribing

Aug 2013 - January 2015


• Stakeholder consultation undertaken through interviews, surveys and workshops


5CPA component Consultation activity With whom Timeframe Action taken in response Service;

• Medicines Australia; • Australian Medical

Association; • Medicare Locals

Network; and • Royal Australian

College of General Practitioners.

• Generic Medicines Industry Association

• National Australian Pharmacy Students' Association (NAPSA)

• Department of Health • Department of Human

Services(Medicare) • Department of

Veteran Affairs • State and Territory

Health Departments

Download - FIFTH COMMUNITY PHARMACY AGREEMENT ... COMMUNITY PHARMACY AGREEMENT CONSULTATION Current as at 30 June 2014 FIFTH COMMUNITY PHARMACY AGREEMENT: OVERVIEW OF STAKEHOLDER CONSULTATION

Top Related